Belmont, CA, United States of America

Kevin McCormack Allan

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 12.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Foster City, CA (US) (2017)
  • San Francisco, CA (US) (2018)
  • Belmont, CA (US) (2020 - 2021)

Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Kevin McCormack Allan: Innovator in Antiviral Compounds

Introduction

Kevin McCormack Allan is a notable inventor based in Belmont, California. He has made significant contributions to the field of antiviral compounds, holding a total of six patents. His work focuses on innovative processes that enhance the preparation of compounds useful in combating viral infections.

Latest Patents

Among his latest patents, one notable invention is the process for preparing antiviral compounds. This patent provides methods for synthesizing compounds that serve as effective antiviral agents. Another significant patent involves methods for preparing bis-tetrahydroisoquinoline-containing compounds, including compounds like (−)-Jorumycin and ecteinascidin 743. These methods also encompass formulations that utilize these compounds for treating proliferative diseases.

Career Highlights

Throughout his career, Kevin has worked with prominent organizations such as Gilead Pharmasset LLC and the California Institute of Technology. His experience in these institutions has allowed him to develop and refine his innovative approaches to antiviral research.

Collaborations

Kevin has collaborated with esteemed colleagues, including Shinji Fujimori and Lars V Heumann. These partnerships have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

Kevin McCormack Allan's contributions to the field of antiviral compounds highlight his innovative spirit and dedication to scientific advancement. His patents reflect a commitment to improving health outcomes through effective antiviral solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…